In particular, approximately 80% of patients with ADPKD have mutations in PKD1, while 15% have mutations in the PKD2 gene; the remaining 5% of patients carry rare mutations in other genes [2,5,6,7,8]. This evidence concerns the gene PKD1 and autosomal dominant polycystic kidney disease.